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Introduction: Diarrhoea is frequently reported in the ICU. Little is known about diarrhoea incidence and the role of
the different risk factors alone or in combination. This prospective observational study aims at determining
diarrhoea incidence and risk factors in the first 2 weeks of ICU stay, focusing on the respective contribution of
feeding, antibiotics, and antifungal drugs.
Methods: Out of 422 patients consecutively admitted into a mixed medical–surgical ICU during a 2-month period,
278 patients were included according to the following criteria: ICU stay >24 hours, no admission diagnosis of
gastrointestinal bleeding, and absence of enterostomy or colostomy. Diarrhoea was defined as at least three liquid
stools per day. Diarrhoea episodes occurring during the first day in the ICU, related to the use of laxative drugs or
Clostridium difficile infection, were not analysed. Multivariate and stratified analyses were performed to determine
diarrhoea risk factors, and the impact of the combination of enteral nutrition (EN) with antibiotics or antifungal
drugs.
Results: A total of 1,595 patient-days were analysed. Diarrhoea was observed in 38 patients (14%) and on 83
patient-days (incidence rate: 5.2 per 100 patient-days). The median day of diarrhoea onset was the sixth day, and
89% of patients had ≤4 diarrhoea days. The incidence of C. difficile infection was 0.7%. Diarrhoea risk factors were
EN covering >60% of energy target (relative risk = 1.75 (1.02 to 3.01)), antibiotics (relative risk = 3.64 (1.26 to 10.51))
and antifungal drugs (relative risk = 2.79 (1.16 to 6.70)). EN delivery per se was not a diarrhoea risk factor. In
patients receiving >60% of energy target by EN, diarrhoea risk was increased by the presence of antibiotics
(relative risk = 4.8 (2.1 to 13.7)) or antifungal drugs (relative risk = 5.0 (2.8 to 8.7)).
Conclusion: Diarrhoea incidence during the first 2 weeks in a mixed population of patients in a tertiary ICU is 14%.
Diarrhoea risk factors are EN covering >60% of energy target, use of antibiotics, and use of antifungal drugs. The
combination of EN covering >60% of energy target with antibiotics or antifungal drugs increases the incidence of
diarrhoea.
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Diarrhoea is often defined as the passage of at least three
liquid stools per day [1]. Diarrhoea is frequently ob-
served in ICU patients, but the reported prevalence dif-
fers according to the definition and the setting, between
2 and 95% [2-6]. The causal factor of diarrhoea is some-
times obvious; that is, Clostridium difficile infection, re-
cent intestinal resection, malabsorptive digestive disease.
However, in most cases, diarrhoea is supposed to be* Correspondence: claude.pichard@unige.ch
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reproduction in any medium, provided the ormultifactorial, without any identified causal factor [7].
Antibiotics, including antifungal drugs, and enteral nu-
trition (EN) are among the most suspected causal factors
of diarrhoea [3,8-10]. However, the role of their combin-
ation in the onset of diarrhoea in the ICU is unclear.
EN is the first choice for nutritional support in the
ICU when the gastrointestinal tract is functional [11].
Some authors argue that EN reduces the incidence
of diarrhoea through a better preservation of intestinal
trophicity and epithelial intestinal barrier function, while
others find a positive relation between EN and diarrhoea
[3,8-10]. EN solutions containing fibres are proposedl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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diarrhoea [12-14]. Diarrhoea is associated with dehydra-
tion, impaired electrolyte balance, bedsores, and
catheter-related infections, and increases the burden of
nursing care and related investigations. In daily clinical
practice, therefore, the onset of diarrhoea frequently
leads to discontinuation of EN [5], which increases the
risk of energy and protein deficit, in turn related to un-
dernutrition and poor clinical outcome [15].
This prospective observational study in a tertiary ICU
population therefore aims to determine, during the 14
first days of ICU stay, the incidence of diarrhoea, the
timing of diarrhoea onset, and the risk factors for diar-
rhoea focusing on the respective contribution of feeding,
antibiotics, and antifungal drugs.
Materials and methods
Patients
This prospective observational study was performed
in consecutive mixed medical–surgical patients ad-
mitted during a 2-month period to the ICU of a tertiary
referral hospital (Geneva University Hospital, Geneva,
Switzerland). All adult patients admitted to the ICU
staying more than 24 hours, with no admission diagnosis
of gastrointestinal bleeding, and without enterostomy or
colostomy, were included in the study (Figure 1). Diar-
rhoea was defined as the elimination of at least three li-
quid stools per day, and was reported by ICU nurses on
the computerised information data management system
(CliniSoft 6.2; General Electric, Milwaukee, WI, USA).
Because the aim of our study was to evaluate the risk of
diarrhoea under the exposure of risk factors in the ICU,
the diarrhoea episodes occurring during the 24 first
hours following ICU admission were not analysed (n = 6
diarrhoea days). Also, diarrhoea occurring during the
48-hour intake of laxative drugs (n = 31 diarrhoea days)
or the diarrhoea associated with a positive laboratory
documentation of C. difficile was not analysed (n = 4
diarrhoea days), since these are well-known causativeAdmitted patients in the ICU 
during the study period (n=422)
Exclusion criteria (n=144)
- GI bleeding (n=9)
- LOS  1 day (n=128)
- enterostomy / colostomy (n=7)
Included patients
n=278
Figure 1 Flowchart of the study cohort. GI, gastrointestinal; LOS,
length of stay.factors of diarrhoea. The following parameters were doc-
umented at ICU admission: age, gender, weight, height,
body mass index (BMI), Acute Physiology and Chronic
Health Evaluation II score [16], Simplified Acute Physi-
ology Score (SAPS) II, diagnosis category, and energy
target. During the 14 first days in the ICU, we collected
the number of liquid stools per day, the use of EN, the
amount of energy delivered by EN, and treatments: anti-
biotics, antiviral, antifungal, laxatives, prokinetics,
probiotics [17], and immunosuppressants. The length of
stay, mortality, the presence of bedsores, use of invasive
and non-invasive ventilations, and renal replacement
therapy were collected at the end of the ICU stay.
This study was approved by the ethical committee of
Geneva University Hospital as a quality of care control
programme (#07-250 (NAC 07–098)), and as such no
patient’s written consent was required.
Feeding strategy
The energy target was defined as recommended by
European Society for Parenteral and Enteral Nutrition
guidelines [11]; that is, 20 to 25 kcal/kg ideal body
weight/day during the 96 first hours of ICU stay,
and thereafter 25 to 30 kcal/kg ideal body weight/day
for females and males, respectively. Anamnestic body
weight was used for patients with BMI ≤20 kg/m2.
EN was started on day 1 after ICU admission in all pa-
tients unable to eat orally at a rate of 20 to 30 ml/hour
up to a maximum of 150 ml/hour, and administered
continuously according to our routine protocols. EN
products consisted of polymeric, fibre-enriched formulas
containing: energy, 1.0 to 1.5 kcal/ml; proteins, 16%;
lipids, 30 to 35% (medium-chain triglycerides 0 to 6%);
and carbohydrates, 49 to 56% of the total provided
energy. Fibres consisted of 22 g/l guar gum or 17.6 g/l
soluble and nonsoluble fibres mix including 7 g/l fructo-
oligosaccharides. EN formulas came from two different
manufacturers (Nestle Medical Nutrition, Vevey, VD,
Switzerland; Abbott AG, Baar, Zg, Switzerland).
Statistical analysis
Baseline characteristics are presented as mean ± stand-
ard deviation or median (minimum; maximum) for
quantitative variables, and as number (percentage) for
qualitative variables. The quantitative variables were
compared using unpaired Student’s t test or the Mann–
Whitney test as appropriate. Proportions were compared
with a chi-square or Fisher’s test as appropriate. The co-
hort characteristics were presented as median (mini-
mum; maximum), and per 100 patient-days.
Only the first 14 days after the ICU admission were
considered for analysis because our study aims to assess
the diarrhoea risk factors during the early phase of the
ICU stay. Diarrhoea incidence was analysed as the
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the total number of patients included, expressed as a
percentage, and the number of days with diarrhoea over
the total number of analysed days during the study period,
expressed per 100 patient-days. Patient-days indicate a unit
of time during which the ICU facilities are used by a
patient; for example, 50 patients in the ICU for 1 day would
represent 50 patient-days. The day of diarrhoea onset was
defined as the day of the first diarrhoea. Diarrhoea days oc-
curring during the first 24 hours, in the 48 hours following
a laxative treatment, and those in the context of C. difficile
infection were not analysed. The latter two were excluded
since they represent well-known aetiologies of diarrhoea.
The risk factors were considered present if observed at least
1 day during the 48 hours before the day with diarrhoea.
The variable ‘EN’ was analysed according to the presence/
absence of EN and the percentage of energy target coverage
≤60% versus >60%. A cutoff value of 60% was chosen be-
cause this is the level of energy coverage (or energy target)
below which ICU patients were considered to have an
energy deficit [18]. The BMI and SAPS II score were
separated according to their median values. The vari-
ables ‘antibiotics’, ‘antifungal drugs’, ‘immunosuppressants’,
and ‘prokinetics’ were analysed according to their presence
or absence. The variable ‘probiotics’ was not analysed
because only two patients did receive probiotics.
To account for the correlation among the repeated
observations for a given subject, the association be-
tween risk factor exposure and diarrhoea was analysed
using the Generalized Estimated Equations model with
a binomial family, a logit link, and an exchangeable
intracorrelation structure [19]. This correlation structure
was selected by the quasi-likelihood criterion [20]. The
standard error of the parameters was adjusted for clus-
tering on patients. From the fitted model, the estimates
of the adjusted risks ratios were obtained with exp{β},
where β is the estimated parameter by the multivariable
Generalized Estimated Equations model. The exposure
to a risk factor is described as the time at risk expressed
in patient-days, and as the incidence rate and estimated
relative risk with 95% confidence interval.
A stratified analysis was performed to measure the
specific effect of antibiotics and antifungal drugs under
EN. Homogeneity assumption was tested using the chi-
square test and overall incidence rate ratios were ad-
justed with Mantel–Haenszel weights [21]. Data analysis
was performed using Stata 12.0 software (College Station,
TX, USA). The two-sided P value was reported and the
significant level was <0.05.
Results
Characteristics of the included patients
Among the 422 patients admitted to the ICU during the
study period (2,038 patient-days), 278 were consecutivelyincluded (Figure 1). A total of 1,595 patient-days were
analysed after exclusion of diarrhoea days occurring
during the first 24 hours in the ICU, of diarrhoea days
occurring during the 48 hours following laxative treat-
ment, or of C. difficile infection. EN, antibiotics, antifun-
gal drugs, immunosuppressants, and prokinetics were
observed during the 48 hours preceding the analysed
patient-day in 69%, 62%, 11%, 5%, and 5% of patient-
days, respectively. Patients’ characteristics according
to the presence or absence of at least 1 day of diarrhoea
are shown in Table 1. Those with diarrhoea were
characterised by a higher proportion of females, respira-
tory and gastrointestinal diagnoses, and low BMI. Pa-
tients with diarrhoea had a more severe disease: high
Acute Physiology and Chronic Health Evaluation II score
and SAPS II at admission, high proportion of bedsores,
and longer ICU length of stay. Age and medical or surgi-
cal types of diagnosis were not significantly different be-
tween the two groups.
Epidemiology of diarrhoea
During the 14 first ICU days, at least 1 day of diarrhoea
was observed in 14% of patients (Tables 1 and 2).
Among the 278 included patients, 42 were sought for a
C. difficile infection at least once during their ICU stay,
but the infection was diagnosed in only two (overall inci-
dence of 0.7%). Out of 1,595 patient-days, 83 were asso-
ciated with diarrhoea: the diarrhoea incidence rate was
5.2 per 100 patient-days (Table 2). The median day of
diarrhoea onset was the sixth day after admission. Table 2
shows the median number of diarrhoea incidents per pa-
tient, the median number of liquid stools per diarrhoea,
and the median day of diarrhoea onset during the 14
first days in the ICU. Figure 2 reports the number of
days with diarrhoea per patient. In 89% of patients, ≤4
diarrhoea days were observed during the ICU stay.
Diarrhoea risk factors
A multivariate analysis using Generalized Estimated
Equations logit regression was performed to determine
the diarrhoea risk factors. The presence of EN per se had
no impact on the risk of diarrhoea (relative risk = 0.87
(0.46 to 1.66)). However, EN, when delivering more than
60% of energy target, increased the risk of diarrhoea by
1.75 (1.02 to 3.01). This effect was not influenced by
gender (data not shown). The other factors significantly
and independently associated with the risk of diarrhoea
were antibiotics and antifungal drugs (Table 3). The
highest relative risk was observed with antibiotics. SAPS
II, BMI, immunosuppressants, and prokinetics were not
associated with the risk of diarrhoea (Table 3).
A stratified analysis was conducted to analyse the risk
of diarrhoea under exposure to a combination of EN
covering more than 60% of the energy target and the
Table 1 Patients’ characteristics according to the presence or absence of diarrhoea
Patients with diarrhoea Patients without diarrhoea P
value(n = 38, 14%) (n = 240, 86%)
At admission
Age (years) 59 ± 17 59 ± 16 0.839
Gender (male/female) 17(45)/21 (55) 155 (65)/85 (35) 0.019
BMI (kg/m2) 23.9 ± 4.3 25.8 ± 4.7 0.029
APACHE II score 25 ± 7 20 ± 8 0.003
SAPS II score 50 ± 17 41 ± 17 0.004
Medical/surgical 25 (66)/13 (34) 143 (60)/97 (40) 0.467
Diagnosis
Gastrointestinal surgery 4 (11) 7 (3) 0.005
Gastrointestinal disease 2 (5) 4 (2) 0.005
Respiratory 14 (37) 43 (18) 0.005
Neurologic 3 (8) 43 (18) 0.005
Cardiac surgery 3 (8) 30 (12) 0.005
Trauma 2 (5) 18 (8) 0.005
Infections (other than respiratory) 3 (8) 15 (6) 0.005
Cardiac arrest 1 (3) 14 (6) 0.005
Myocardial ischemia 1 (3) 45 (19) 0.005
Other 5 (13) 21 (9) 0.005
During ICU stay
Ventilation
Invasive 27 (71) 133 (55) 0.070
Non-invasive 8 (21) 34 (14) 0.271
Renal replacement therapy 3 (8) 11 (5) 0.417
Bedsore 10 (26) 12 (5) <0.001
Length of stay (days) 15 ± 14 6 ± 7 <0.001
Death in the ICU 6 (16) 27 (11) 0.421
Diarrhoea was defined as at least three liquid or soft stools per day. Values are number (%) or mean ± standard deviation. APACHE, Acute Physiology and Chronic
Health Evaluation; BMI, body mass index; SAPS, Simplified Acute Physiology Score.
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analysis showed that antibiotics and antifungal drugs in-
creased the diarrhoea incidence whatever the coverage
level of the energy target (Table 4). In patients receiving
more than 60% of the energy target by EN in combin-
ation with antibiotics or antifungal drugs, the diarrhoea
incidence was fivefold increased in comparison withTable 2 Epidemiology of diarrhoea during the 14 first days o
Variable Units
Diarrhoea incidence Diarrh
Number of patients with diarrhoea n (%)
Number of diarrhoea days per patient Media
Number of liquid stools per diarrhoea Media
Days of diarrhoea onset Media
Diarrhoea was defined as at least three liquid stools per day. Diarrhoea incidence ispatients receiving more than 60% of the energy target by
EN without antibiotics or antifungal drugs.
Discussion
This study shows that 14% of patients presented at least
1 day of diarrhoea during the first 2 weeks in the ICU.
The diarrhoea risk factors are the use of antibiotics andf the ICU stay
Data
oea days (per 100 patient–days) 83 (5.2)
38 (14)
n (range) 1 (1; 10)
n (range) 4 (3; 16)
n (range) 6 (2; 14)
reported as patient-days by the total of the 1,595 analysed patient-days.
Figure 2 Number of diarrhoea days in patients with at least 1
day of diarrhoea. The number of diarrhoea days were measured in
patients with at least 1 day of diarrhoea in the first 14 days in the
ICU. The first 24 hours in the ICU were not analysed. Diarrhoea was
defined as at least three liquid stools per day. The percentage of
patients with 1 to 10 diarrhoea days is indicated at the top of bars.
The percentage of patients with ≤4 and >4 diarrhoea days was 89
and 11, respectively.
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is covering >60% of the energy target. The combination
of EN covering >60% of the energy target with antibi-
otics or antifungal drugs increases diarrhoea incidence,
and should be considered the main diarrhoea risk factor.
These results clearly suggest that EN, even if covering
>60% of the energy target, should not be incriminated as
the sole cause of diarrhoea in the ICU.
The prevalence of diarrhoea in ICU patients has been
previously reported from 2 and 95% [10]. This variation
is explained by different methodologies. In our study,
the World Health Organisation definition of diarrhoea
was chosen [1]. Because weighing stools in the routineTable 3 Diarrhoea risk factors
Exposure Number of diarr
on exposur(patient-days)
Baseline characteristics
SAPS II >48 vs. ≤48 702 39
BMI ≥25 kg/m2 vs. <25 kg/m2 760 39
Risk factor exposure
EN >60% vs. ≤60% energy target 835 59
Antibiotics: yes vs. no 817 73
Antifungal drugs: yes vs. no 142 36
Immunosuppressants: yes vs. no 69 24
Prokinetics: yes vs. no 63 4
Diarrhoea was defined as at least three liquid or soft stools per day. The exposure t
preceding a diarrhoea day. BMI, body mass index; CI, confidence interval; EN, enter
with Generalized Estimated Equations logit regression.practice of ICU is practically almost impossible, defining
diarrhoea as at least three liquid stools per day appears
to be the most applicable criteria in daily practice and
the best reflection of ICU caregivers’ workload induced
by diarrhoea. Our incidence of diarrhoea (14%) is lower
than that reported by others [3,22]. In the study by Jack
and colleagues, diarrhoea was reported in 78% of a sub-
group of patients with continuous enteral feeding [3],
whereas patients with parenteral nutrition or oral feed-
ing were not excluded from our study. By including only
patients with EN and other specific criteria, the study by
Jack and colleagues has selected a subgroup of patients
at higher risk of diarrhoea. However, our study certainly
underestimated the overall risk of diarrhoea in the ICU,
since the occurrence of diarrhoea was limited to the first
14 days in the ICU, and the first 24 hours in the ICU
were excluded from the analysis. However, our results
are comparable with other studies performed in medical
and surgical ICUs, which found a prevalence of diar-
rhoea of 9% [5,8]. The design of the study by Montejo
was close to ours: prospective inclusion of 400 patients
during a consecutive period of 1 month [5,8].
Based on older studies [23,24], C. difficile infection is
always suspected when diarrhoea occurs in the ICU,
mainly in patients with antibiotics [25]. In our tertiary
ICU, a low incidence of C. difficile infection (0.7%) was
observed. This is in accordance with studies that found
no C. difficile infection in cohorts of 39 and 72 ICU pa-
tients with diarrhoea, respectively [3,26]. These results
indicate that C. difficile infection is nowadays a rare
cause of diarrhoea in the ICU. However, because of
its potentially severe consequences and transmission,
C. difficile infection has to be sought in case of diarrhoea
in ICU patients.
In this study, antifungal or antibiotics drugs were iden-
tified as independent risk factors for diarrhoea. However,
the analysis of the contribution of the different classes ofhoea days
e time
Incidence rate Estimated relative riska
(per 100 patient-days) 95% CI P value
5.56 1.48 (0.64; 3.41) 0.356
5.13 0.77 (0.30; 1.97) 0.595
7.07 1.75 (1.02; 3.01) 0.042
8.94 3.64 (1.26; 10.51) 0.017
25.35 2.79 (1.16; 6.70) 0.022
34.78 1.95 (0.57; 6.71) 0.287
6.35 1.44 (0.28; 7.38) 0.659
o risk factors was present if the factor was observed during the 48 hours
al nutrition; SAPS, Simplified Acute Physiology Score. aRelative risk estimated
Table 4 Impact of the combination of enteral nutrition with antibiotics or antifungal drugs on diarrhoea incidence
Exposure Number of diarrhoea days
on exposure time
Incidence rate Incidence rate ratioa
(patient-days) (per 100 patient-days) (95% CI)
EN ≤60% energy target
Absence of antibiotics 169 4 7.6 3.2 (1.1; 12.9)
Presence of antibiotics 264 20
EN >60% energy target
Absence of antibiotics 295 6 9.8 4.8 (2.1; 13.7)
Presence of antibiotics 540 53
EN ≤60% energy target
Absence of antifungal drugs 353 17 22.2 10.6 (4.3; 27.4)
Presence of antifungal drugs 54 12
EN >60% energy target
Absence of antifungal drugs 822 30 27.3 5.0 (2.8; 8.7)
Presence of antifungal drugs 88 24
The exposure to risk factors was present if the factor was observed during the 48 hours preceding a diarrhoea day. Diarrhoea was defined as at least three liquid
stools per day. CI, confidence interval; EN, enteral nutrition. aStratified analysis: incidence rate ratio adjusted with Mantel–Haenszel weights.
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were too small. This limitation has to be addressed in fu-
ture studies.
EN is a diarrhoea risk factor only when the EN is de-
livering >60% of the energy target. This clearly suggests
that the EN volume, outflow, and the amount of deliv-
ered energy may play a role. Early EN constitutes the
first choice of nutritional support in the ICU when the
gastrointestinal tract is functional [11]. This recommen-
dation is supported by the presumed beneficial effects of
EN on the intestinal trophicity and epithelial intestinal
barrier, and clinical outcome [27], and by its lower
material-related costs in comparison with parenteral nu-
trition [28]. The role of EN in the onset of diarrhoea has
long been suspected [29], but a recent meta-analysis did
not suggest an increased diarrhoea risk with EN as com-
pared with parenteral nutrition [30]. Because other fac-
tors could increase the diarrhoea risk, diarrhoea onset in
ICU patients treated with EN must not be systematically
considered a nonfunctionality of the gastrointestinal
tract and should not lead to the systematic discontinu-
ation of EN. The reduction or discontinuation of EN
would increase the risk for EN of protein-energy deficit
[31,32], which is associated with an increased complica-
tion rate [15,33]. Recently, a randomised controlled trial
indicated that preventing energy deficit with supplemen-
tal parenteral nutrition could decrease the rate of infec-
tions in ICU patients with EN failure [18], but its impact
on the risk of diarrhoea has never been studied. One
could hypothesise that by limiting the energy coverage
by EN, supplemental parenteral nutrition could decrease
the risk of diarrhoea. Nevertheless, in the absence of
interventional clinical studies, the management of diar-
rhoea is still based on nonvalidated protocols [2]. Todate, the best management of EN-associated diarrhoea is
its prevention, based on the respect of EN initiation and
administration rules. If EN is considered the primary
cause of diarrhoea, changes in the administration flow
rate or replacement of the EN solution can be consid-
ered. As only fibre-enriched EN formulas were used in
this study, the effect of delivering more than 60% of the
energy target with nonfibre-enriched formulas could not
be determined.
In our study, patients with diarrhoea were most fre-
quently women and had lower BMI. This would have
been due to the fact that females, because of their lower
weight, and patients with lower BMI are more frequently
covering more than 60% of their energy target. However,
BMI and female gender were not found to be
confounding factors for diarrhoea risk. As reported by
others [3,5,22], patients with diarrhoea had higher dis-
ease severity scores at admission and a higher ICU
length of stay. However, our study does not allow the
conclusion that diarrhoea is associated with worse clin-
ical outcome. Indeed, the putative confounding factors
were not studied, since this was beyond the scope of the
study. Nevertheless, the higher proportion of patients
with bedsores in the diarrhoea subgroup strongly sug-
gests that diarrhoea could have an impact on the risk of
complications [34], ICU caregivers’ workload, and costs.
Conclusion
The incidence of diarrhoea is 14% during the first 2
weeks in a mixed population of patients in a tertiary re-
ferral ICU. Delivering more than 60% of the energy
target by EN, antibiotics, and antifungal drugs are diar-
rhoea risk factors. Diarrhoea risk is further increased
when EN covering more than 60% of the energy target is
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are needed to better understand diarrhoea physiopathol-
ogy when EN and antibiotics or antifungal drugs are
combined in ICU patients in order to optimise the clin-
ical care and cost management.
Key messages
 EN is a diarrhoea risk factor only when covering at
least 60% of the energy target.
 The combination of antibiotics or antifungal drugs
with EN delivering more than 60% of the energy
target markedly increased the risk of diarrhoea.
 Of ICU patients, 14% experience at least 1 day of
diarrhoea.
 Of diarrhoea episodes, 89% last 4 days or less.
 C. difficile infection was an infrequent cause of
diarrhoea: incidence of 0.7%.
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